Cargando…

Biomarkers of Guillain-Barré Syndrome: Some Recent Progress, More Still to Be Explored

Guillain-Barré syndrome (GBS), the axonal subtype of which is mainly triggered by C. jejuni with ganglioside-mimicking lipooligosaccharides (LOS), is an immune-mediated disorder in the peripheral nervous system (PNS) accompanied by the disruption of the blood-nerve barrier (BNB) and the blood-cerebr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ying, Sun, Shuang, Zhu, Jie, Cui, Li, Zhang, Hong-Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588351/ https://www.ncbi.nlm.nih.gov/pubmed/26451079 http://dx.doi.org/10.1155/2015/564098

Ejemplares similares

Adult-onset Still’s disease complicated by Guillain-Barré syndrome
por: Farina, Nicola, et al.
Publicado: (2023)

Serum Folate Correlates with Severity of Guillain-Barré Syndrome and Predicts Disease Progression
por: Gao, Yang, et al.
Publicado: (2018)

Guillain-Barré syndrome: rehabilitation outcome and recent developments.
por: Melillo, E. M., et al.
Publicado: (1998)

Guillain–Barré syndrome
por: Mirian, Ario, et al.
Publicado: (2021)

Identification of CSF biomarkers by proteomics in Guillain-Barré syndrome
por: Li, Pei, et al.
Publicado: (2018)

Progress in Guillain–Barré syndrome immunotherapy—A narrative review of new strategies in recent years
por: Yao, Jiajia, et al.
Publicado: (2023)

Covid-19 and Guillain-Barré syndrome: More than a coincidence!
por: El Otmani, H., et al.
Publicado: (2020)

Hyperreflexic Guillain-Barré syndrome
por: Baheti, Neeraj N., et al.
Publicado: (2010)

An Update in Guillain-Barré Syndrome
por: Winer, J. B.
Publicado: (2014)

Guillain–Barré syndrome mimics
por: Tham, Sai Leong, et al.
Publicado: (2018)

Syndrome de Guillain–Barré
por: Mirian, Ario, et al.
Publicado: (2021)

Vision Loss in Guillain-Barre Syndrome: Is it a Complication of Guillain-Barre Syndrome or Just a Coincidence?
por: Ramakrishnan, Sri, et al.
Publicado: (2016)

More Severe Manifestations and Poorer Short-Term Prognosis of Ganglioside-Associated Guillain-Barré Syndrome in Northeast China
por: Wu, Xiujuan, et al.
Publicado: (2014)

Motor Nerve Conduction Block Predicting Outcome of Guillain-Barre Syndrome
por: Niu, Jingwen, et al.
Publicado: (2018)

Treatment guidelines for Guillain–Barré Syndrome
por: Meena, A. K., et al.
Publicado: (2011)

Brucellosis, Presenting with Guillain-Barré Syndrome
por: Babamahmoodi, Farhang, et al.
Publicado: (2011)

Guillain-Barre syndrome and mood disorders
por: Neroutsos, Evangelos, et al.
Publicado: (2010)

Syringomyelia Coexisting With Guillain-Barre Syndrome
por: Kim, Hee-Sang, et al.
Publicado: (2013)

Fulminant Guillain-Barré Syndrome with Myocarditis
por: Mishra, Ajay, et al.
Publicado: (2014)

Prognosis of Guillain-Barré Syndrome in Children
por: SALEHIOMRAN, Mohammad Reza, et al.
Publicado: (2016)

Outbreak of Guillain-Barre syndrome in Peru
por: Díaz-Soto, S., et al.
Publicado: (2019)

Guillain-Barré syndrome in times of pandemics
por: Leonhard, Sonja E, et al.
Publicado: (2020)

COVID-19 and Guillain-Barré syndrome
por: Joob, B., et al.
Publicado: (2020)

Guillain-Barre Syndrome, Neuroborreliosis, or Both
por: Owens, Joey, et al.
Publicado: (2020)

AZD-1222: Guillain-Barre syndrome
Publicado: (2021)

Mimics and Chameleons in Guillain-Barré Syndrome
por: ., Fadila, et al.
Publicado: (2021)

Autoantibody screening in Guillain–Barré syndrome
por: Lleixà, Cinta, et al.
Publicado: (2021)

BAMLANIVIMAB-INDUCED GUILLAIN-BARRÉ SYNDROME
por: PALAGUACHI, GLADYS, et al.
Publicado: (2021)

Neuroborreliosis Presenting as Guillain-Barré Syndrome
por: Farr, Jacob, et al.
Publicado: (2023)

Guillain-Barré syndrome as clinical presentation of a recently acquired hepatitis C
por: Boccia, Filomena, et al.
Publicado: (2023)

Neurofilament light chain as biomarker for axonal damage in Guillain-Barré syndrome
por: Jacobs, Bart C
Publicado: (2021)

Extensive cytokine biomarker analysis in serum of Guillain-Barré syndrome patients
por: Li, Xiaocong, et al.
Publicado: (2023)

Detection of anti-ganglioside antibodies in Guillain-Barré syndrome
por: Zhu, Wenli, et al.
Publicado: (2021)

Risk factors for the severity of Guillain-Barré syndrome and predictors of short-term prognosis of severe Guillain-Barré syndrome
por: Wen, Puyuan, et al.
Publicado: (2021)

Guillain-Barre syndrome following COVID-19 vaccines: A review of literature
por: Yu, Miao, et al.
Publicado: (2023)

Exploring the experiences of having Guillain‐Barré Syndrome: A qualitative interview study
por: Akanuwe, Joseph N. A., et al.
Publicado: (2020)

Intensive Care and Treatment of Severe Guillain–Barré Syndrome
por: Shang, Pei, et al.
Publicado: (2021)

The Role of Apolipoprotein E in Guillain-Barré Syndrome and Experimental Autoimmune Neuritis
por: Zhang, Hong-liang, et al.
Publicado: (2010)

Remnant Cholesterol and Dyslipidemia Are Risk Factors for Guillain–Barré Syndrome and Severe Guillain–Barré Syndrome by Promoting Monocyte Activation
por: Ding, Yaowei, et al.
Publicado: (2022)

Fasting Glucose Levels Correlate with Disease Severity of Guillain-Barré Syndrome
por: Wang, Ying, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9t5t7b0r2tpdmcfnvhlcc6g2uk